导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 48.95% | 274/2269 |
| 近一周 | -1.09% | 2102/2338 |
| 近一月 | -2.69% | 1920/2330 |
| 近一季 | 7.87% | 244/2324 |
| 近半年 | 47.70% | 214/2303 |
| 近一年 | 43.57% | 254/2260 |
| 近两年 | 72.26% | 138/2185 |
| 近三年 | 44.41% | 230/2063 |
| 成立以来 | 218.00% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
7.92% 299/2331 |
-3.78% 2176/2353 |
44.11% 222/2347 |
- - |
| 2024 | 12.49% 349/2336 |
-11.91% 2191/2322 |
0.48% 725/2326 |
21.07% 82/2322 |
4.97% 295/2336 |
| 2023 | -9.88% 1195/2330 |
5.70% 536/2290 |
-6.60% 1856/2303 |
-6.83% 1353/2318 |
-2.01% 874/2330 |
| 2022 | -22.20% 1496/2299 |
-18.32% 1584/2227 |
7.51% 716/2269 |
-17.59% 2103/2294 |
7.50% 137/2300 |
| 2021 | 27.03% 249/2205 |
-4.65% 1457/2009 |
31.69% 68/2060 |
-4.11% 1495/2103 |
5.49% 482/2208 |
| 2020 | 70.89% 310/2086 |
-1.68% 1177/1861 |
22.68% 535/1950 |
16.56% 288/2010 |
21.56% 193/2031 |
| 2019 | 51.89% 276/1974 |
25.21% 912/3053 |
0.88% 914/3201 |
6.46% 571/1861 |
12.95% 225/1886 |
| 2018 | -32.15% 1573/1913 |
- - |
-8.90% 2349/2983 |
-9.57% 2549/2970 |
-12.19% 2374/2975 |
| 2017 | 18.05% 248/1885 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 创金合信全球医药生物股票发起(QDII)C | 1.8048 | 37.74% |
| 泰信现代服务业混合 | 2.0450 | 32.88% |
| 易方达标普生物科技人民币A | 1.7298 | 28.02% |
| 永赢高端装备智选混合发起A | 1.1625 | 27.65% |
| 永赢高端装备智选混合发起C | 1.1467 | 27.52% |
| 金信稳健策略混合A | 2.2741 | 23.08% |
| 金信精选成长混合A | 1.6584 | 22.49% |
| 金信精选成长混合C | 1.6361 | 22.31% |
| 东方人工智能主题混合C | 1.5534 | 22.12% |
| 金信行业优选混合发起式A | 2.7474 | 21.61% |
| 广发鑫益混合 VS. () |